Table 3.
The significantly altered metabolites in the comparison of HC and aMCI.
| Metabolite | P-value |
|---|---|
| Sterol lipids | |
| 16:3 Cholesteryl ester | 0.0000275 |
| 1alpha-hydroxy-22-[3-(1-hydroxy-1-methylethyl)phenyl]-23,24,25.26,27- pentanorvitaminD3/1alpha-hydroxy-22-[3-(1-hydroxy-1-methylethyl)phen -yl]-23,24,25,26,27-pentanorcholecalciferol |
0.00054943 |
| Sphingolipids | |
| PE-Cer(d14:2(4E,6E)/16:0(2OH)) | 0.0000327 |
| N-(tetradecanoyl)-deoxysphing-4-enine-1-sulfonate | 0.0000358 |
| Ganglioside GM3 (d18:1/9Z-18:1) | 0.00030583 |
| Glycerophospholipids | |
| LPIM1(19:0/0:0) | 0.0000897 |
| CL(8:0/11:0/18:2(9Z,11Z)/18:2(9Z,11Z)) | 0.0013938 |
| PG(P-16:0/12:0) | 0.0015922 |
| PI(P-20:0/22:2(13Z,16Z)) | 0.0024846 |
| Fatty Acyls | |
| IC202B | 0.00012983 |
| Lysine-containing siolipin | 0.00033586 |
| Saccharolipids | |
| DAT(19:0/25:0(2Me[S],3OH[S],4Me[S],6Me[S])) | 0.0020767 |
| Others | |
| Nonoxynol-9 | 0.0000601 |
| 2-Decaprenyl-6-methoxyphenol | 0.00027562 |
| Remikiren | 0.00036897 |
| Hydroxydestruxin B | 0.00052018 |
| Drotaverine | 0.0006352 |
| Neuromedin B | 0.00074886 |